IDEXX Laboratories Inc
(WBO:IDXX)
€
469.5
4 (0.86%)
Market Cap: 38.76 Bil
Enterprise Value: 39.39 Bil
PE Ratio: 48.79
PB Ratio: 26.62
GF Score: 38/100 - Q1 2024 IDEXX Laboratories Inc Earnings Call TranscriptMay 01, 2024Earnings
- IDEXX Laboratories Inc at Bank of America Animal Health Summit (Virtual) TranscriptFeb 29, 2024
- Q4 2023 IDEXX Laboratories Inc Earnings Call TranscriptFeb 05, 2024€520.2 (+6.08%)Earnings
- IDEXX Laboratories Inc Investor and Analyst Session TranscriptJan 15, 2024
- IDEXX Laboratories Inc at Goldman Sachs Healthcare C-Suite Unscripted Conference TranscriptJan 04, 2024
- Q3 2023 IDEXX Laboratories Inc Earnings Call TranscriptNov 01, 2023€366.4 (-3.66%)Earnings
- IDEXX Laboratories Inc Investor Day TranscriptAug 10, 2023
- Q2 2023 IDEXX Laboratories Inc Earnings Call TranscriptAug 01, 2023€484.1 (-3.53%)Earnings
- IDEXX Laboratories Inc at Stifel Jaws & Paws Conference (Virtual) TranscriptMay 31, 2023
- Q1 2023 IDEXX Laboratories Inc Earnings Call TranscriptMay 02, 2023€420.8 (-3.86%)Earnings
- IDEXX Laboratories Inc at Raymond James Institutional Investors Conference TranscriptMar 06, 2023
- IDEXX Laboratories Inc at Bank of America Animal Health Summit (Virtual) TranscriptMar 02, 2023
- Q4 2022 IDEXX Laboratories Inc Earnings Call TranscriptFeb 06, 2023€459.95 (+1.66%)Earnings
- IDEXX Laboratories Inc at Goldman Sachs CEOs Unscripted Conference TranscriptJan 05, 2023
- Q3 2022 IDEXX Laboratories Inc Earnings Call TranscriptNov 01, 2022€391.9 (+7.61%)Earnings
- IDEXX Laboratories Inc Investor Day TranscriptAug 11, 2022
- Q2 2022 IDEXX Laboratories Inc Earnings Call TranscriptAug 02, 2022€396.4 (+1.78%)Earnings
- IDEXX Laboratories Inc at Stifel Jaws & Paws Conference TranscriptJun 01, 2022
- Q1 2022 IDEXX Laboratories Inc Earnings Call TranscriptMay 04, 2022€382.3 (-7.50%)Earnings
- IDEXX Laboratories Inc at Raymond James Institutional Investors Conference TranscriptMar 07, 2022
- IDEXX Laboratories Inc at Bank of America Animal Health Summit (Virtual) TranscriptFeb 24, 2022
- Q4 2021 IDEXX Laboratories Inc Earnings Call TranscriptFeb 02, 2022€477.4 (+5.41%)Earnings
- Q3 2021 IDEXX Laboratories Inc Earnings Call TranscriptNov 02, 2021€546 (-4.48%)Earnings
- IDEXX Laboratories Inc Investor Day (Virtual) TranscriptAug 12, 2021
- Q2 2021 IDEXX Laboratories Inc Earnings Call TranscriptJul 30, 2021€566.2 (-4.07%)Earnings
- IDEXX Laboratories Inc at Stifel Jaws & Paws Conference (Virtual) TranscriptJun 02, 2021
- IDEXX Laboratories Inc Annual Shareholders Meeting TranscriptMay 12, 2021
- Q1 2021 IDEXX Laboratories Inc Earnings Call TranscriptMay 04, 2021€443 (-2.62%)Earnings
- IDEXX Laboratories Inc at Raymond James Institutional Investors Conference (Virtual) TranscriptMar 01, 2021
- IDEXX Laboratories Inc at Bank of America Corporation Virtual Animal Health Summit TranscriptFeb 25, 2021
- Q4 2020 IDEXX Laboratories Inc Earnings Call TranscriptFeb 02, 2021€424.3 (+4.33%)Earnings
- Q3 2020 IDEXX Laboratories Inc Earnings Call TranscriptOct 29, 2020€381.3 (+4.38%)Earnings
- IDEXX Laboratories Inc Investor Day 2020 TranscriptAug 13, 2020
- Q2 2020 IDEXX Laboratories Inc Earnings Call TranscriptJul 31, 2020€339.9 (+8.91%)Earnings
- IDEXX Laboratories Inc at Stifel Jaws & Paws Conference TranscriptMay 27, 2020
- IDEXX Laboratories Inc Annual Shareholders Meeting TranscriptMay 06, 2020
- Q1 2020 IDEXX Laboratories Inc Earnings Call TranscriptApr 30, 2020€257.1 (+4.05%)Earnings
- IDEXX Laboratories Inc at Raymond James Institutional Investors Conference TranscriptMar 02, 2020
- IDEXX Laboratories Inc at Bank of America Merrill Lynch Animal Health Summit TranscriptFeb 24, 2020
- Q4 2019 IDEXX Laboratories Inc Earnings Call TranscriptJan 31, 2020€246.1 (-2.77%)Earnings
- Q3 2019 IDEXX Laboratories Inc Earnings Call TranscriptOct 31, 2019€254.7 (+4.09%)Earnings
- IDEXX Laboratories Inc Investor Day ( a discussion with an IDEXX customer and veterinary) TranscriptAug 15, 2019
- IDEXX Laboratories Inc Investor Day (overall companion) TranscriptAug 14, 2019
- Q2 2019 IDEXX Laboratories Inc Earnings Call TranscriptAug 01, 2019€246.35 (-3.81%)Earnings
- IDEXX Laboratories Inc at William Blair Growth Stock Conference TranscriptJun 05, 2019
- IDEXX Laboratories Inc at Stifel Dental & Veterinary Conference TranscriptMay 29, 2019
- IDEXX Laboratories Inc Annual Shareholders Meeting TranscriptMay 08, 2019
- Q1 2019 IDEXX Laboratories Inc Earnings Call TranscriptMay 01, 2019€206.16Earnings
- IDEXX Laboratories Inc at Raymond James Institutional Investors Conference TranscriptMar 04, 2019
- IDEXX Laboratories Inc at Bank of America Merrill Lynch Animal Health Summit TranscriptFeb 25, 2019
- Q4 2018 IDEXX Laboratories Inc Earnings Call TranscriptFeb 01, 2019€179.36 (-2.94%)Earnings
IDEXX Laboratories Inc at Bank of America Merrill Lynch Animal Health Summit Transcript
Feb 25, 2019 / 03:55PM GMT
Release Date Price:
€186.11
(+1.68%)
Michael Leonidovich Ryskin
BofA Merrill Lynch, Research Division - Associate
With us, we've got IDEXX Laboratories, and we're hosting Brian McKeon, CFO; and Jay Mazelsky, VP and Head of North American CAG business. So I want to thank you very much for coming in. Pleasure to have you as always.
Brian P. McKeon
IDEXX Laboratories, Inc. - CFO, Executive VP & Treasurer
Thanks, Mike.
Questions & Answers
Michael Leonidovich Ryskin
BofA Merrill Lynch, Research Division - Associate
I think we'll start with just a quick overview. I mean, can you recap 2018 for us? Do you have an eventful year, a lot of things going on? What do you see in the business? And sort of what's your view of the industry as we sit here today?
Brian P. McKeon
IDEXX Laboratories, Inc. - CFO, Executive VP & Treasurer
Yes, we had a -- thanks for having us here today, Mike. We, at IDEXX, had an excellent year in 2018. One of the key metrics we focus on is our companion animal diagnostics
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent ![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust_rating.png)
4.6 out of 5
Trustpilot
![](https://static.gurufocus.com/trust.png)